INVVY
Price:
$21.8455
Market Cap:
$1.50B
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy products that include Temgesic, Burpex, and Buprenex. The company operates in approximately 40 countries worldwide. Indivior PLC has research collaboration agreement with Addex Therapeutics Ltd. The company was inc...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2015-06-09
Stock Exchange
PNK
Ticker
INVVY
According to Indivior PLC’s latest financial reports and current stock price. The company's current Current Ratio is 0.83. This represents a change of -7.11% compared to the average of 0.89 of the last 4 quarters.
The mean historical Current Ratio of Indivior PLC over the last ten years is 1.48. The current 0.83 Current Ratio has changed 5.51% with respect to the historical average. Over the past ten years (40 quarters), INVVY's Current Ratio was at its highest in in the December 2021 quarter at 1.80. The Current Ratio was at its lowest in in the September 2024 quarter at 0.83.
Average
1.48
Median
1.53
Minimum
0.96
Maximum
1.98
Discovering the peaks and valleys of Indivior PLC Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 49.24%
Maximum Annual Current Ratio = 1.98
Minimum Annual Increase = -31.21%
Minimum Annual Current Ratio = 0.96
Year | Current Ratio | Change |
---|---|---|
2023 | 0.97 | -21.56% |
2022 | 1.24 | -31.21% |
2021 | 1.80 | -9.37% |
2020 | 1.98 | 8.12% |
2019 | 1.83 | 12.81% |
2018 | 1.62 | 13.26% |
2017 | 1.43 | 49.24% |
The current Current Ratio of Indivior PLC (INVVY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.33
5-year avg
1.56
10-year avg
1.48
Indivior PLC’s Current Ratio is less than Orexo AB (publ) (1.70), less than Genomma Lab Internacional, S.A.B. de C.V. (1.81), less than Hypera S.A. (1.81), greater than Sumitomo Pharma Co., Ltd. (0.64), less than Elanco Animal Health Incorporated (2.55), less than SIGA Technologies, Inc. (8.10), less than Esperion Therapeutics, Inc. (1.85), less than Catalent, Inc. (2.51), less than Neurocrine Biosciences, Inc. (4.37), less than Amphastar Pharmaceuticals, Inc. (3.43), less than Collegium Pharmaceutical, Inc. (0.97), less than Ironwood Pharmaceuticals, Inc. (3.62), less than ANI Pharmaceuticals, Inc. (2.74), less than Alpha Teknova, Inc. (4.73), less than Guardion Health Sciences, Inc. (16.67), less than Lifecore Biomedical, Inc. (1.83), less than Organogenesis Holdings Inc. (3.09), less than Petros Pharmaceuticals, Inc. (0.85), less than Pacira BioSciences, Inc. (2.25), less than Intra-Cellular Therapies, Inc. (7.66), less than Alkermes plc (3.45), less than Eagle Pharmaceuticals, Inc. (1.70),
Company | Current Ratio | Market cap |
---|---|---|
1.70 | $38.58M | |
1.81 | $1.27B | |
1.81 | $1.90B | |
0.64 | $1.64B | |
2.55 | $5.87B | |
8.10 | $429.09M | |
1.85 | $450.22M | |
2.51 | $11.52B | |
4.37 | $13.83B | |
3.43 | $1.84B | |
0.97 | $938.48M | |
3.62 | $737.73M | |
2.74 | $1.14B | |
4.73 | $457.91M | |
16.67 | $4.35M | |
1.83 | $279.15M | |
3.09 | $398.55M | |
0.85 | $2.96M | |
2.25 | $897.61M | |
7.66 | $9.04B | |
3.45 | $4.79B | |
1.70 | $6.74M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Indivior PLC using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Indivior PLC or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Indivior PLC's Current Ratio?
How is the Current Ratio calculated for Indivior PLC (INVVY)?
What is the highest Current Ratio for Indivior PLC (INVVY)?
What is the 3-year average Current Ratio for Indivior PLC (INVVY)?
What is the 5-year average Current Ratio for Indivior PLC (INVVY)?
How does the current Current Ratio for Indivior PLC (INVVY) compare to its historical average?